|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Innovative Drug Delivery Systems, Inc. (IDDS) Releaes: CMO Dan Carr Promoted To Chief Executive Officer
10/19/2005 5:09:25 PM
NEW YORK--(BUSINESS WIRE)--July 6, 2005--Intrac, Inc. (OTC BB: ITRD) and its wholly-owned subsidiary Innovative Drug Delivery Systems (IDDS), a developer of novel pain relief treatments, promoted Daniel B. Carr, M.D. to the position of Chief Executive Officer. In addition to his new duties as CEO, Dr. Carr, will continue to serve as Chief Medical Officer of IDDS, a position he has held since September 2004. Dr, Carr has served on IDDS's Scientific Advisory Board since 2000 and is an internationally recognized expert on pain and its treatment. Dr. Carr has served on advisory boards for Johnson and Johnson, Purdue Pharma, Endo Pharmaceuticals, Abbott Laboratories and a number of other pharmaceutical industry companies. In addition, he has served as a consultant or board member of the American Pain Society, the American Academy of Pain Medicine, the International Association for the Study of Pain, the Legislative Task Force on Pain for the Commonwealth of Massachusetts, the Joint Commission for the Accreditation of Healthcare Organizations and the National Institutes for Health Clinical Center Pain and Palliative Care Working Group.
|
|
|
|
|
|
|
|
|
|
|